Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
374M
-
Number of holders
-
343
-
Total 13F shares, excl. options
-
252M
-
Shares change
-
+8.74M
-
Total reported value, excl. options
-
$7.4B
-
Value change
-
+$247M
-
Put/Call ratio
-
0.89
-
Number of buys
-
159
-
Number of sells
-
-140
-
Price
-
$29.32
Significant Holders of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) as of Q2 2021
437 filings reported holding BHC - Bausch Health Companies Inc. - Common Shares, No Par Value as of Q2 2021.
Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) has 343 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 252M shares
of 374M outstanding shares and own 67.48% of the company stock.
Largest 10 shareholders include ICAHN CARL C (34.1M shares), PAULSON & CO. INC. (25.8M shares), ValueAct Holdings, L.P. (17.9M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (16.3M shares), VANGUARD GROUP INC (9.31M shares), GOLDENTREE ASSET MANAGEMENT LP (8.17M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.85M shares), Laurion Capital Management LP (6.8M shares), Parallax Volatility Advisers, L.P. (6.17M shares), and MORGAN STANLEY (5.61M shares).
This table shows the top 343 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.